Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus [Phase 4]
A Phase 4 trial compares pitavastatin plus ezetimibe against high-intensity statin therapy to evaluate the risk of new-onset diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering [Phase 4]
Phase 4 clinical trial updating LDL-C optimization with inclisiran for patients in whom drug-drug interactions limit LDL lowering; currently…
-
FDA approval · 2025-04-10FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
The FDA approved a supplemental application for rosuvastatin calcium from Puracap Laboratories LLC dba Blu Pharmaceuticals, granting approva…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction) [NA]
This entry notes the CAPTURE clinical trial studying polyglucosamine for prevention and treatment of atherosclerotic disease, which is curre…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]
Phase 2 trial of LY3473329 in adults with elevated lipoprotein(a) at high risk for cardiovascular events has completed and results have been…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector
This entry reports the completion of a non-interventional study evaluating monthly 300 mg alirocumab (PRALUENT) administered using the SYDNE…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease [NA]
This clinical trial update notes a study evaluating coated or chewable aspirin with a hybrid strategy to mitigate adverse effects of air pol…
-
FDA approval · 2025-03-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium by Aurobindo Pharma Limited.
-
FDA approval · 2025-03-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium from Cipla USA Inc., authorizing changes to the existing generic product.
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for pravastatin sodium, a generic statin, approving changes to the product's la…
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for pravastatin sodium from Accord Healthcare Inc., supporting continued regulatory approval for thi…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease [NA]
This completed clinical trial, sponsored by Heart Force Medical Inc., evaluated the diagnostic accuracy of seismocardiography for coronary a…
-
FDA approval · 2025-03-13FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for atorvastatin calcium filed by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-03-12FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for rosuvastatin (generic rosuvastatin), authorizing its marketing in the Unit…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease [NA]
This clinical trial update describes an ongoing study evaluating the effectiveness of decision-support tools for cardiovascular risk managem…
-
FDA approval · 2025-03-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for atorvastatin calcium, expanding the availability of a generic statin product.
-
FDA approval · 2025-02-24FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-02-24FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium submitted by Aurobindo Pharma Limited. This action pertains to the generic pr…
-
FDA approval · 2025-02-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for Pravastatin Sodium submitted by Quallent, indicating an approved change to the product under an …
-
FDA label_change · 2025-02-12FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) to support the sprinkle dosage-form labeling. This action expand…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia [Phase 3]
A Phase 3 study evaluating the efficacy and safety of HST101 in Chinese patients with hypercholesterolemia and related dyslipidemias; the tr…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
The REVEALPLAQUE trial, a prospective multicenter study using coronary CT angiography to analyze plaque, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease [NA]
A completed clinical trial evaluating behavioral economic approaches to increase physical activity among patients at elevated risk for cardi…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) [NA]
The v-ASCERTAIN implementation study sponsored by Monash University has been terminated, involving conditions including atherosclerotic card…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Effect of Ezetimibe on Gut Microbiota [Phase 4]
Phase 4 clinical trial evaluating the effect of ezetimibe on gut microbiota in patients with atherosclerotic cardiovascular disease and dysl…